Walleye Capital’s Apyx Medical APYX Stock Holding History

Walleye Capital’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-23,084	Closed	-$151K	–	2336
2022 Q1	$151K	Buy	+23,084	New	+$227K	﹤0.01%	1624

Other funds holding APYX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.25% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

Invenire Partners Ridgefield, Connecticut $65.4M AUM 18.1% 1-Year Est. Return

Walleye Capital's APYX Position: Q2 2022 in Review

Walleye Capital sold out of Apyx Medical (APYX) in Q2 2022, closing a stake of 23,084 shares — an estimated $151K sold.

Walleye Capital first reported a position in APYX in Q1 2022 and held it in 1 quarter. The position peaked at $151K in Q1 2022. 63 funds tracked by Wall St. Rank hold APYX as of Q2 2022.

Walleye Capital reported no remaining Apyx Medical position as of Q2 2022 after selling out during the quarter.
Walleye Capital sold 23,084 Apyx Medical shares in Q2 2022, an estimated $151K.
Walleye Capital first reported a position in Apyx Medical in Q1 2022 and held it in 1 quarter.
Walleye Capital's Apyx Medical position peaked at $151K in Q1 2022.
63 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2022.

Based on Walleye Capital's 13F filing for Q2 2022, filed 8 Aug 2022.